市場調査レポート

商品コード

1593475

細胞計数市場規模、シェア、成長分析、製品別、用途別、エンドユーザー別、地域別 - 産業予測、2024年～2031年

Cell Counting Market Size, Share, Growth Analysis, By Product, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日: 2024年11月10日
発行: SkyQuest
ページ情報: 英文 189 Pages
納期: 3～5営業日

価格

PDF & Excel (Single User License)

USD 5,300 763,518円

レポートPDF・Excelを1 名様のみがご利用頂けるライセンスです。PDF・Excell内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します

PDF & Excel (Multiple User License)

USD 6,200 893,172円

レポートPDF・Excel2-5名様までがご利用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

PDF & Excel (Enterprise License)

USD 7,100 1,022,826円

レポートPDF・Excelを同一企業に所属の全世界の方にご使用頂けるライセンスです。PDF・Excel内のテキスト等のコピーは可能です。PDF・Excelの印刷は可能ですが、印刷したもののご利用はPDF・Excelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
目次

概要

サンプル依頼リストに入れる

細胞計数の世界市場規模は2022年に98億米ドルと評価され、2023年の104億7,000万米ドルから2031年には177億2,000万米ドルに成長し、予測期間（2024-2031年）のCAGRは6.80%で成長する見通しです。

細胞計数市場は、細胞生物学、がん研究、免疫学などの分野における研究への注目の高まりによって力強い成長を遂げています。この市場拡大の主な要因は、個別化医療に対する需要の高まり、慢性疾患患者の急増、細胞計数技術の継続的な進歩です。しかし、技術的な複雑さやこれらの技術を運用する熟練者の不足といった課題が、市場成長の障害となっています。こうした制約があるにもかかわらず、革新的な技術のイントロダクションと細胞ベースの治療の重要性の高まりによって業界が進化しているため、見通しは依然として明るいです。さらに、デジタル技術の統合が細胞計数の手法を変革し、市場の可能性をさらに高めています。その結果、細胞計数市場は上昇基調を維持し、医療研究や診断における多様な用途に対応し、最終的にはヘルスケア成果の質を高めることが期待されます。

市場概要
消耗品
- 培地血清試薬
- アッセイキット
- マイクロプレート
- アクセサリー
- その他の消耗品
機器
- 分光光度計
- シングルモードリーダー
- マルチモードリーダー
- フローサイトメーター
- 血液分析装置
- 完全自動分析装置
- 半自動血液分析装置
- 細胞カウンター
- 自動細胞カウンター
- 血球計算盤/手動細胞カウンター
- 顕微鏡

細胞計数市場：用途別

市場概要
調査用途
- がん調査
- 免疫学調査
- 神経学調査
- 幹細胞調査
- その他の調査用途
医療用途
- 非侵襲的出生前診断
- 体外受精
- 循環腫瘍細胞の検出
産業用途

細胞計数市場：エンドユーザー別

市場概要
調査機関
病院および診断研究所
製薬・バイオテクノロジー企業および調査受託機関（CROS）
その他のエンドユーザー

細胞計数市場：地域別

市場概要
北米
- 米国
- カナダ
欧州
- ドイツ
- スペイン
- フランス
- 英国
- イタリア
- その他欧州地域
アジア太平洋地域
- 中国
- インド
- 日本
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- その他ラテンアメリカ地域
中東・アフリカ（MEA）
- アラブ首長国連邦諸国
- 南アフリカ
- その他中東・アフリカ地域

競合情勢

上位5社の比較
主要企業の市場ポジショニング（2023年）
主な市場企業が採用した戦略
市場における最近の活動
主要企業の市場シェア（2023年）

主要企業プロファイル

Danaher Corporation（US）
Thermo Fisher Scientific（US）
Becton, Dickinson and Company（US）
Merck KGaA（Germany）
Bio-Rad Laboratories Inc.（US）
Abbott Laboratories（US）
PerkinElmer, Inc.（US）
Agilent Technologies, Inc.（US）
Corning（US）
Tecan（Switzerland）
Boule Diagnostics AB（Sweden）
Olympus Corporation（Japan）
Horiba（Japan）
Sysmex Corporation（Japan）
Siemens Healthineers AG（Germany）
F. Hoffmann-La Roche AG（Switzerland）
Luminex Corporation（US）
Nexcelom Bioscience LLC（US）
Tip Biosystems（Singapore）
Logos Biosystems, Inc.（South Korea）

Product Code: SQMIG35H2305

Global Cell Counting Market size was valued at USD 9.8 billion in 2022 and is poised to grow from USD 10.47 billion in 2023 to USD 17.72 billion by 2031, growing at a CAGR of 6.80% during the forecast period (2024-2031).

The cell counting market is witnessing robust growth driven by the increasing focus on research in areas such as cell biology, cancer research, and immunology. This market expansion is primarily fueled by the rising demand for personalized medicine, the surge in chronic disease cases, and ongoing advancements in cell counting technologies. However, challenges such as technical complexities and a shortage of skilled personnel to operate these technologies present hurdles to market growth. Despite these constraints, the outlook remains positive as the industry evolves with the introduction of innovative technologies and the rising significance of cell-based therapies. Additionally, the integration of digital technologies is transforming cell counting methods, further boosting market potential. As a result, the cell counting market is expected to continue its upward trajectory, accommodating a diverse range of applications in medical research and diagnostics, and ultimately enhancing the quality of healthcare outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Counting market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Cell Counting Market Segmental Analysis

Global Cell Counting Market is segmented by Product, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Application, the market is segmented into Research Applications, Medical Applications, and Industrial Applications. Based on End User, the market is segmented into Research Institutes, Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROS), and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Cell Counting Market

The Global Cell Counting market is significantly driven by major advancements in technology, including the development of superior automated cell counters, high-tech flow cytometers, and enhanced imaging systems. These innovations enhance the reliability and efficiency of cell counting processes, thereby increasing demand across various sectors such as clinical diagnostics and research. The improved accuracy and speed of these advanced systems not only facilitate precise cell analysis but also contribute to better clinical outcomes and research efficacy. As healthcare and life sciences continue to emphasize the importance of accurate diagnostics and data-driven research, the demand for advanced cell counting solutions is poised for robust growth.

Restraints in the Global Cell Counting Market

One significant market restraint affecting the Global Cell Counting market is the limited reimbursement options available for certain cell counting systems in various regions. This inadequacy can negatively influence the financial feasibility of adopting advanced technologies, thereby detracting from potential demand. The financial burden on researchers and healthcare providers arising from insufficient reimbursement may deter them from exploring and investing in novel cell counting solutions, ultimately impeding innovation and growth in the sector. As a result, the hesitance to embrace cutting-edge cell counting technologies due to reimbursement issues poses a considerable challenge to market expansion and development.

Market Trends of the Global Cell Counting Market

The Global Cell Counting Market is witnessing a notable trend characterized by a heightened emphasis on assessing cell functionality and viability, moving beyond traditional counting methods. Researchers and clinicians are increasingly recognizing the importance of evaluating cell activity and health, particularly in applications such as drug development, cancer research, and regenerative medicine. This demand is driving innovation in technologies that not only quantify cells but also provide comprehensive insights into cellular behavior. As a result, novel solutions are being developed to enhance the accuracy and efficiency of cell viability assays, thereby expanding the scope of applications and fostering growth within the market.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Regulatory Analysis
Value Chain Analysis
Case Study Analysis

Cell Counting Market by Product

Market Overview
Consumables
- Media, Sera, And Reagents
- Assay Kits
- Microplates
- Accessories
- Other Consumables
Instruments
- Spectrophotometers
- Single-Mode Readers
- Multi-Mode Readers
- Flow Cytometers
- Hematology Analyzers
- Fully Automated Analyzers
- Semi-Automated Hematology Analyzers
- Cell Counters
- Automated Cell Counters
- Hemocytometers/Manual Cell Counters
- Microscopes

Cell Counting Market by Application

Market Overview
Research Applications
- Cancer Research
- Immunology Research
- Neurology Research
- Stem Cell Research
- Other Research Applications
Medical Applications
- Noninvasive Prenatal Diagnosis
- In Vitro Fertilization
- Circulating Tumor Cell Detection
Industrial Applications

Cell Counting Market by End User

Market Overview
Research Institutes
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies and Contract Research Organizations (CROS)
Other End Users

Cell Counting Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tecan (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boule Diagnostics AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Olympus Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Horiba (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexcelom Bioscience LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Tip Biosystems (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Logos Biosystems, Inc. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments